Gastro-intestinal microbes degrading dietary gluten
胃肠道微生物降解膳食麸质
基本信息
- 批准号:8467668
- 负责人:
- 金额:$ 38.28万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-06-01 至 2015-05-31
- 项目状态:已结题
- 来源:
- 关键词:AdenocarcinomaAdherenceAllergicAmino AcidsAnemiaBacteriaBiological AssayBiological ModelsBiologyCD4 Positive T LymphocytesCarbohydratesCeliac DiseaseCleaved cellClinicalCloningComplexDental PlaqueDietDigestionDiseaseDrug Metabolic DetoxicationEnvironmentEnzymesEukaryotic CellFecesFluorescence Resonance Energy TransferFoodGastrointestinal tract structureGenesGliadinGlutamineGlutenGlycoside HydrolasesHabitatsHealthHigh Pressure Liquid ChromatographyHumanImmune System DiseasesImmunologicsIn VitroIntestinesInvestigationLaboratoriesLifeLiquid substanceLower Gastrointestinal TractLymphomaMalignant NeoplasmsMalnutritionMeasurementMetabolicMetabolismMicrobeNutrientOralOral cavityOrganOsteoporosisPancreasPatientsPeptide HydrolasesPeptidesPreparationPrevalenceProbioticsProlineProtein FamilyProteinsReactionRecombinantsRecoveryRibosomal RNARiskRoleSalivaSalivarySiteSourceSpecificitySpecimenStomachStructureSymbiosisT-Cell ProliferationTimeToxic effectWorkbasecombatcytotoxicdietary restrictiongastrointestinalgluteninimmunogenicin vivoin vivo Modelinterestmicrobialmicrobial colonizationmicroorganismmouse modelnovelproline-rich proteinspublic health relevanceresponse
项目摘要
DESCRIPTION (provided by applicant): The gastrointestinal tract is a major reservoir of a wide variety of microorganisms. The role of the colonizing microorganisms in contributing to host metabolic processes and overall gastrointestinal health is becoming more widely recognized. Recent work in our laboratory has revealed that bacteria residing in the oral cavity, the entrance to the gastrointestinal tract, are able to degrade dietary gluten. Glutens elicit immunologic reactions and serious clinical conditions in patients suffering from celiac disease. The basis of this disease is an auto-immune disorder in which a host-anti-self response is triggered by gluten-derived cytotoxic peptides. Patients with overt celiac disease suffer from gastroenteropathy and are at risk for malnutrition, anemia, osteoporosis and gastrointestinal malignancies such as lymphoma and adenocarcinoma. To avoid gluten toxicity, patients are required to adherence to a strict gluten-free diet, which is currently the only treatment option available. However, the dietary restriction approach requires a life-long commitment and represents a significant burden to the patient. The discovery of natural gluten degrading microorganisms from the oral cavity opens a promising new avenue in the quest to neutralize the deleterious effects of glutens. The current application seeks to explore the proteolytic activities of resident gastrointestinal microorganisms and study their potential to fragment gluten proteins into non-toxic peptides. The specific aims are: (1) To identify gluten-degrading microorganism(s) in dental plaque and fecal specimens; (2) To define protease cleavage site specificity and assess the abolishment of immunogenic gliadin regions, and to determine pH activity profiles; (3) To assess gliadin detoxification by selected microbes and purified enzyme preparations in a T-cell proliferation assay and in an in vivo model for celiac disease; (4) To characterize, clone and recombinantly express the gene(s) of the most promising enzyme(s). Reduction of gluten toxicity by natural colonizers of the gastrointestinal tract would offer novel treatment perspectives in the form of probiotics or applications of pure gluten-degrading enzymes.
描述(由申请人提供):胃肠道是多种微生物的主要储存库。定植微生物在促进宿主代谢过程和整体胃肠道健康方面的作用正得到越来越广泛的认识。我们实验室最近的研究表明,居住在胃肠道入口的口腔中的细菌能够降解饮食中的麸质。谷蛋白会引起乳糜泻患者的免疫反应和严重的临床症状。这种疾病的基础是一种自身免疫性疾病,其中宿主抗自我反应是由谷蛋白衍生的细胞毒性肽引发的。患有明显乳糜泻的患者患有胃肠病,并且有营养不良、贫血、骨质疏松和胃肠道恶性肿瘤(如淋巴瘤和腺癌)的风险。为了避免麸质毒性,患者必须坚持严格的无麸质饮食,这是目前唯一可用的治疗选择。然而,饮食限制方法需要终身承诺,对患者来说是一个重大负担。从口腔中发现的天然谷蛋白降解微生物为寻求中和谷蛋白的有害影响开辟了一条有希望的新途径。目前的应用旨在探索常驻胃肠道微生物的蛋白水解活性,并研究它们将麸质蛋白片段成无毒肽的潜力。具体目的是:(1)鉴定牙菌斑和粪便标本中的谷蛋白降解微生物;(2)确定蛋白酶裂解位点特异性,评估免疫原性麦胶蛋白区域的消除,并确定pH活性谱;(3)在t细胞增殖试验和乳糜泻体内模型中评估选定微生物和纯化酶制剂对麦胶蛋白的解毒作用;(4)鉴定、克隆和重组表达最有前途的酶基因。通过胃肠道的自然定植物减少谷蛋白毒性将以益生菌的形式或纯谷蛋白降解酶的应用提供新的治疗前景。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Eva Josephine Helmerhorst其他文献
Eva Josephine Helmerhorst的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Eva Josephine Helmerhorst', 18)}}的其他基金
Oral microbial enzymes for the treatment of celiac disease
用于治疗乳糜泻的口腔微生物酶
- 批准号:
8509426 - 财政年份:2013
- 资助金额:
$ 38.28万 - 项目类别:
Oral microbial enzymes for the treatment of celiac disease
用于治疗乳糜泻的口腔微生物酶
- 批准号:
9275335 - 财政年份:2013
- 资助金额:
$ 38.28万 - 项目类别:
Oral microbial enzymes for the treatment of celiac disease
用于治疗乳糜泻的口腔微生物酶
- 批准号:
8681349 - 财政年份:2013
- 资助金额:
$ 38.28万 - 项目类别:
Oral microbial enzymes for the treatment of celiac disease
用于治疗乳糜泻的口腔微生物酶
- 批准号:
9067914 - 财政年份:2013
- 资助金额:
$ 38.28万 - 项目类别:
Gastro-intestinal microbes degrading dietary gluten
胃肠道微生物降解膳食麸质
- 批准号:
8279469 - 财政年份:2010
- 资助金额:
$ 38.28万 - 项目类别:
Gastro-intestinal microbes degrading dietary gluten
胃肠道微生物降解膳食麸质
- 批准号:
8662167 - 财政年份:2010
- 资助金额:
$ 38.28万 - 项目类别:
Gastro-intestinal microbes degrading dietary gluten
胃肠道微生物降解膳食麸质
- 批准号:
8073930 - 财政年份:2010
- 资助金额:
$ 38.28万 - 项目类别:
Gastro-intestinal microbes degrading dietary gluten
胃肠道微生物降解膳食麸质
- 批准号:
7993182 - 财政年份:2010
- 资助金额:
$ 38.28万 - 项目类别:
Oral Fluid Proteolytic Effects on Salivary Protein Structure and Function
口腔液蛋白水解对唾液蛋白质结构和功能的影响
- 批准号:
7595090 - 财政年份:2008
- 资助金额:
$ 38.28万 - 项目类别:
Oral Fluid Proteolytic Effects on Salivary Protein Structure and Function
口腔液蛋白水解对唾液蛋白质结构和功能的影响
- 批准号:
7470858 - 财政年份:2008
- 资助金额:
$ 38.28万 - 项目类别:
相似海外基金
I-Corps: Medication Adherence System
I-Corps:药物依从性系统
- 批准号:
2325465 - 财政年份:2023
- 资助金额:
$ 38.28万 - 项目类别:
Standard Grant
Improving Repositioning Adherence in Home Care: Supporting Pressure Injury Care and Prevention
提高家庭护理中的重新定位依从性:支持压力损伤护理和预防
- 批准号:
490105 - 财政年份:2023
- 资助金额:
$ 38.28万 - 项目类别:
Operating Grants
An innovative, AI-driven prehabilitation platform that increases adherence, enhances post-treatment outcomes by at least 50%, and provides cost savings of 95%.
%20创新、%20AI驱动%20康复%20平台%20%20增加%20依从性、%20增强%20治疗后%20结果%20by%20at%20至少%2050%、%20和%20提供%20成本%20节省%20of%2095%
- 批准号:
10057526 - 财政年份:2023
- 资助金额:
$ 38.28万 - 项目类别:
Grant for R&D
CO-LEADER: Intervention to Improve Patient-Provider Communication and Medication Adherence among Patients with Systemic Lupus Erythematosus
共同领导者:改善系统性红斑狼疮患者的医患沟通和药物依从性的干预措施
- 批准号:
10772887 - 财政年份:2023
- 资助金额:
$ 38.28万 - 项目类别:
Nuestro Sueno: Cultural Adaptation of a Couples Intervention to Improve PAP Adherence and Sleep Health Among Latino Couples with Implications for Alzheimer’s Disease Risk
Nuestro Sueno:夫妻干预措施的文化适应,以改善拉丁裔夫妇的 PAP 依从性和睡眠健康,对阿尔茨海默病风险产生影响
- 批准号:
10766947 - 财政年份:2023
- 资助金额:
$ 38.28万 - 项目类别:
Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
- 批准号:
10594350 - 财政年份:2023
- 资助金额:
$ 38.28万 - 项目类别:
Unintrusive Pediatric Logging Orthotic Adherence Device: UPLOAD
非侵入式儿科记录矫形器粘附装置:上传
- 批准号:
10821172 - 财政年份:2023
- 资助金额:
$ 38.28万 - 项目类别:
Antiretroviral therapy adherence and exploratory proteomics in virally suppressed people with HIV and stroke
病毒抑制的艾滋病毒和中风患者的抗逆转录病毒治疗依从性和探索性蛋白质组学
- 批准号:
10748465 - 财政年份:2023
- 资助金额:
$ 38.28万 - 项目类别:
Improving medication adherence and disease control for patients with multimorbidity: the role of price transparency tools
提高多病患者的药物依从性和疾病控制:价格透明度工具的作用
- 批准号:
10591441 - 财政年份:2023
- 资助金额:
$ 38.28万 - 项目类别:
Development and implementation of peer-facilitated decision-making and referral support to increase uptake and adherence to HIV pre-exposure prophylaxis in African Caribbean and Black communities in Ontario
制定和实施同行协助决策和转介支持,以提高非洲加勒比地区和安大略省黑人社区对艾滋病毒暴露前预防的接受和依从性
- 批准号:
491109 - 财政年份:2023
- 资助金额:
$ 38.28万 - 项目类别:
Fellowship Programs














{{item.name}}会员




